FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Citizen Petition Seeks Database for Medical Device Labels

[ Price : $8.95]

A patient safety advocacy group files a citizen petition urging FDA to create a comprehensive public database of medical device la...

$17.9 Million Settlement in Generic Drug Price-Fixing Case

[ Price : $8.95]

New York Attorney General Letitia James and a bipartisan coalition of 47 other attorneys general secure $17.85 million from drug m...

FDA Accepts Exelixis NDA for Metastatic Colorectal Cancer

[ Price : $8.95]

FDA accepts for review an Exelixis NDA for zanzalintinib in combination with the immune checkpoint inhibitor atezolizumab for pati...

Complete Response on Pharmings Pediatric sNDA for Joenja

[ Price : $8.95]

FDA issues Pharming Group a complete response letter for its supplemental NDA seeking expanded approval of Joenja (leniolisib) for...

Floridas FDA-Authorized Canadian Drug Import Program Stalls

[ Price : $8.95]

Floridas FDA-authorized drug importation program stalls and has yet to deliver any imported medicines more than two years after re...

Warning Letter Sent to Beta Bionics

[ Price : $8.95]

FDA issues Beta Bionics a Warning Letter following an inspection of the companys Irvine, CA, facility conducted 6/2025.

FDA Updates Device Inspection Program Due to QMSR Move

[ Price : $8.95]

FDA discontinues the use of its Quality System Inspection Technique for medical device inspections and will instead conduct inspec...

Grail Submits Final PMA Module for Cancer Blood Test

[ Price : $8.95]

Grail files the final module of its PMA for the companys multi-cancer early detection blood test.

Biogen Breakthrough Status for Lupus Therapy

[ Price : $8.95]

FDA awards Biogen a breakthrough therapy designation for its experimental antibody litifilimab for treating cutaneous lupus erythe...

Senators Question HHS Oversight of TrumpRx Platform

[ Price : $8.95]

A group of Democratic senators ask HHS Office of Inspector General to clarify how it will oversee direct-to-consumer prescription ...